التالي
Hello. Were Haleon. A new world-leading consumer health company. Shaped by all who join us. Together were improving everyday health for billions of people. By growing and innovating our global portfolio of category-leading brands including Sensodyne Panadol Advil Voltaren Theraflu Ot
Hello. Were Haleon. A new world-leading consumer health company. Shaped by all who join us. Together were improving everyday health for billions of people. By growing and innovating our global portfolio of category-leading brands including Sensodyne Panadol Advil Voltaren Theraflu Ot
Are you passionate about advancing patient outcomes while driving launch successGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increa
Are you passionate about advancing patient outcomes while driving launch successGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increa
As an Associate Director of Quantitative Systems Pharmacology (QSP) Expert you will develop and apply QSP models to guide clinical study designs and mechanistic interpretation of study results in support of development of treatments and combination of treatments for a variety of disea
As an Associate Director of Quantitative Systems Pharmacology (QSP) Expert you will develop and apply QSP models to guide clinical study designs and mechanistic interpretation of study results in support of development of treatments and combination of treatments for a variety of disea
(Senior) Medical Affairs Manager Vaccines (m/f/d)Bei GSK vereinen wir Wissenschaft Technologie und Talente um gemeinsam Krankheiten voraus zu sein. Unser ImpfstoffTeam ist ein zentraler Pfeiler dieser Mission mit dem klaren Anspruch Menschen durch evidenzbasierte Medizin und starke P
(Senior) Medical Affairs Manager Vaccines (m/f/d)Bei GSK vereinen wir Wissenschaft Technologie und Talente um gemeinsam Krankheiten voraus zu sein. Unser ImpfstoffTeam ist ein zentraler Pfeiler dieser Mission mit dem klaren Anspruch Menschen durch evidenzbasierte Medizin und starke P
Are you passionate about advancing patient outcomes while driving launch successGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increa
Are you passionate about advancing patient outcomes while driving launch successGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increa
POSTING END DATE: Friday May 1 2026 / 5P EDTBusiness IntroductionAt GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our underst
POSTING END DATE: Friday May 1 2026 / 5P EDTBusiness IntroductionAt GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our underst
Position SummaryYou will be a key member of the Digital Medicine team shaping strategy and delivery of digital tools that support development and safe use of medicines. You will work across research clinical development regulatory data science and commercial teams. We seek a collabora
Position SummaryYou will be a key member of the Digital Medicine team shaping strategy and delivery of digital tools that support development and safe use of medicines. You will work across research clinical development regulatory data science and commercial teams. We seek a collabora
GSKs success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders its also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired encouraged and challenged to be th
GSKs success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders its also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired encouraged and challenged to be th
Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol
Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol
Posting Title: Internship: Investigation & Process Improvement Intern Italy 2026Help us get ahead of disease together with our Investigation & Process Improvement team!Education required: Preferred BS degree in management engineering or scientific background.Other requirements:Univers
Posting Title: Internship: Investigation & Process Improvement Intern Italy 2026Help us get ahead of disease together with our Investigation & Process Improvement team!Education required: Preferred BS degree in management engineering or scientific background.Other requirements:Univers
GSK hat ehrgeizige kommerzielle Ziele für die Zukunft. Bis 2031 wollen wir einen Umsatz von 38 Milliarden jährlich erzielen basierend auf dem bestehenden starken Leistungstrend der den positiven Einfluss den wir auf die Gesundheit von Milliarden von Patienten weltweit haben können er
GSK hat ehrgeizige kommerzielle Ziele für die Zukunft. Bis 2031 wollen wir einen Umsatz von 38 Milliarden jährlich erzielen basierend auf dem bestehenden starken Leistungstrend der den positiven Einfluss den wir auf die Gesundheit von Milliarden von Patienten weltweit haben können er
Job PurposeThe Medical Innovation & Performance role is accountable for elevating Medical Affairs from effective execution to measurable enterprise performance. The role shapes and enables the regional Medical agenda through a combination of strategic leadership operating discipline a
Job PurposeThe Medical Innovation & Performance role is accountable for elevating Medical Affairs from effective execution to measurable enterprise performance. The role shapes and enables the regional Medical agenda through a combination of strategic leadership operating discipline a
Position territory: San FranciscoViiV Healthcare is a global specialty HIV company the only one that is 100% focused on researching and delivering new medicines for people living with and at risk of HIV. ViiV Healthcare is highly mission-driven in our unrelenting commitment to being a
Position territory: San FranciscoViiV Healthcare is a global specialty HIV company the only one that is 100% focused on researching and delivering new medicines for people living with and at risk of HIV. ViiV Healthcare is highly mission-driven in our unrelenting commitment to being a
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
We are a specialist pharmaceutical company 100% dedicated to developing medicines to treat and prevent HIV. Born out of a partnership between GSK and Pfizer in 2009 with Shionogi joining in 2012 our ambition is to end the HIV epidemic.As the pioneers in HIV innovation we constantly lo
We are a specialist pharmaceutical company 100% dedicated to developing medicines to treat and prevent HIV. Born out of a partnership between GSK and Pfizer in 2009 with Shionogi joining in 2012 our ambition is to end the HIV epidemic.As the pioneers in HIV innovation we constantly lo
Are you passionate about advancing patient outcomes while driving launch successGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increa
Are you passionate about advancing patient outcomes while driving launch successGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increa
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
As part of the new product introduction and product transfer activities you will be supporting and leading validation activities for major projects at our Singapore site. You will ensure compliance to quality systems during validation activities and work closely with manufacturing and
As part of the new product introduction and product transfer activities you will be supporting and leading validation activities for major projects at our Singapore site. You will ensure compliance to quality systems during validation activities and work closely with manufacturing and
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient
Business IntroductionWe manufacture and supply reliable high-quality medicines and vaccines to meet patients needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of medicines and 409 million vaccine doses in 2024 to
Business IntroductionWe manufacture and supply reliable high-quality medicines and vaccines to meet patients needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of medicines and 409 million vaccine doses in 2024 to
